Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

Market open

 --Real time quotes

Oct 4, 2022, 11:59 a.m.

/zigman2/quotes/201168308/composite

$

6.47

Change

+0.53 +8.86%

Volume

Volume 81,213

Real time quotes

/zigman2/quotes/201168308/composite

Previous close

$ 5.94

$ 6.47

Change

+0.53 +8.86%

Day low

Day high

$6.16

$6.48

Open

52 week low

52 week high

$5.25

$48.00

Open

David A. Roth

Presently, David A. Roth holds the position of Chief Medical Officer at Syros Pharmaceuticals, Inc.

Dr. Roth previously was Chief Medical Officer & Executive Vice President at iRobot Corp., Chief Medical Officer & Executive Vice President at Infinity Pharmaceuticals, Inc., Vice President & Head-Early Development at Pfizer Inc. and Assistant Vice President-Clinical Research at Wyeth Pharmaceuticals LLC (a subsidiary of Pfizer Inc.) and Member of Massachusetts Institute of Technology.

He received an undergraduate degree from Massachusetts Institute of Technology and a doctorate from Harvard Medical School.

Transactions

Date Shares Transaction Value
04/01/2022 27,281   Derivative/Non-derivative trans. at $1.12 per share. 30,555
02/12/2019 87,000   Award at $0 per share. 0

Officers and Executives

Dr. Nancy A. Simonian
President, Chief Executive Officer & Director
Mr. Jason Haas
Chief Financial Officer
Dr. Eric R. Olson
Chief Scientific Officer
Dr. David A. Roth
Chief Medical Officer
Ms. Kristin Stephen
Chief Development Officer
Mr. Conley Chee
Chief Commercial Officer
Dr. Richard A. Young
Director
Mr. Peter Wirth
Chairman
Mr. Mark J. Alles
Independent Director
Dr. S. Gail Eckhardt
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Dr. Phillip A. Sharp
Independent Director
Ms. Marsha H. Fanucci
Independent Director
Dr. Amir H. Nashat
Independent Director
Dr. Srinivas Akkaraju
Independent Director
Link to MarketWatch's Slice.